Cancer Tissue Diagnostics Market

Market Study on Cancer Tissue Diagnostics: Growing Prevalence of Cancer Cases, Advancements in Precision Medicine, Increasing Cancer Prevalence, and the Soaring Demand for Personalized and Targeted Therapies

A Detailed Analysis of the Cancer Tissue Diagnostics Market Based on Spotlight on Oncology, An Astonishing Rise in Cancer Prevalence, and Technological Advancements

- Table of Content -

1. Executive Summary

    1.1. Global Cancer Tissue Diagnostics Market Snapshot, 2023 and 2030

    1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events   

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Challenges

        2.2.5. Key Trends

    2.3. Test Type Lifecycle Analysis

    2.4. Cancer Tissue Diagnostics Market: Value Chain

        2.4.1. List of Raw Material Supplier

        2.4.2. List of Manufacturers

        2.4.3. List of Distributors

        2.4.4. List of Applications

        2.4.5. Profitability Analysis

    2.5. Porter Five Force's Analysis

    2.6. Geopolitical Tensions: Market Impact   

    2.7. Macro-Economic Factors

        2.7.1. Global Sectorial Outlook

        2.7.2. Global GDP Growth Outlook

        2.7.3. Global Parent Market Overview

    2.8. Forecast Factors - Relevance and Impact

    2.9. Regulatory and Technology Landscape

3. Global Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    3.1. Key Highlights

        3.1.1. Market Volume (Units) Projections

        3.1.2. Market Size and Y-o-Y Growth

        3.1.3. Absolute $ Opportunity

    3.2. Market Size (US$ Mn) Analysis and Forecast

        3.2.1. Historical Market Size Analysis, 2013-2016

        3.2.2. Current Market Size Forecast, 2018-2026

    3.3. Global Cancer Tissue Diagnostics Market Outlook: Test Type

        3.3.1. Introduction / Key Findings

        3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022

        3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

            3.3.3.1. Breast Cancer

            3.3.3.2. Stomach (Gastric) Cancer

            3.3.3.3. Colorectal Cancer 

            3.3.3.4. Prostate Cancer

            3.3.3.5. Others

    3.4. Market Attractiveness Analysis: Test Type

    3.5. Global Cancer Tissue Diagnostics Market Outlook: In Situ Hybridization (ISH) Test

        3.5.1. Introduction / Key Findings

        3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By In Situ Hybridization (ISH) Test, 2018 - 2022

        3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

            3.5.3.1. Breast Cancer

            3.5.3.2. Non-Small Cell Lung Cancer (NSCLC)

            3.5.3.3. Bladder Cancer

            3.5.3.4. Others

    3.6. Market Attractiveness Analysis: In Situ Hybridization (ISH) Test

4. Global Cancer Tissue Diagnostics Market Outlook: Region

    4.1. Key Highlights

    4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022

    4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030

        4.3.1. North America

        4.3.2. Europe

        4.3.3. East Asia

        4.3.4. South Asia and Oceania

        4.3.5. Latin America

        4.3.6. Middle East & Africa (MEA)

    4.4. Market Attractiveness Analysis: Region

5. North America Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030) 

    5.1. Key Highlights

    5.2. Pricing Analysis

    5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        5.3.1. By Country

        5.3.2. By Test Type

        5.3.3. By In Situ Hybridization (ISH) Test

    5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        5.4.1. U.S.

        5.4.2. Canada

    5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

        5.5.1. Breast Cancer

        5.5.2. Stomach (Gastric) Cancer

        5.5.3. Colorectal Cancer

        5.5.4. Prostate Cancer

        5.5.5. Others

    5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

        5.6.1. Breast Cancer

        5.6.2. Non-Small Cell Lung Cancer (NSCLC)

        5.6.3. Bladder Cancer

        5.6.4. Others

    5.7. Market Attractiveness Analysis

6. Europe Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    6.1. Key Highlights

    6.2. Pricing Analysis

    6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        6.3.1. By Country

        6.3.2. By Test Type

        6.3.3. By In Situ Hybridization (ISH) Test

    6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        6.4.1. Germany

        6.4.2. France

        6.4.3. U.K.

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Russia

        6.4.7. Türkiye

        6.4.8. Rest of Europe

    6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

        6.5.1. Breast Cancer

        6.5.2. Stomach (Gastric) Cancer

        6.5.3. Colorectal Cancer

        6.5.4. Prostate Cancer

        6.5.5. Others

    6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

        6.6.1. Breast Cancer

        6.6.2. Non-Small Cell Lung Cancer (NSCLC)

        6.6.3. Bladder Cancer

        6.6.4. Others

    6.7. Market Attractiveness Analysis

7. East Asia Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    7.1. Key Highlights

    7.2. Pricing Analysis

    7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        7.3.1. By Country

        7.3.2. By Test Type

        7.3.3. By In Situ Hybridization (ISH) Test

    7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        7.4.1. China

        7.4.2. Japan

        7.4.3. South Korea

    7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

        7.5.1. Breast Cancer

        7.5.2. Stomach (Gastric) Cancer

        7.5.3. Colorectal Cancer

        7.5.4. Prostate Cancer

        7.5.5. Others

    7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

        7.6.1. Breast Cancer

        7.6.2. Non-Small Cell Lung Cancer (NSCLC)

        7.6.3. Bladder Cancer

        7.6.4. Others

    7.7. Market Attractiveness Analysis

8. South Asia & Oceania Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    8.1. Key Highlights

    8.2. Pricing Analysis

    8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        8.3.1. By Country

        8.3.2. By Test Type

        8.3.3. By In Situ Hybridization (ISH) Test

    8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        8.4.1. India

        8.4.2. Southeast Asia

        8.4.3. ANZ

        8.4.4. Rest of South Asia & Oceania

    8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

        8.5.1. Breast Cancer

        8.5.2. Stomach (Gastric) Cancer

        8.5.3. Colorectal Cancer

        8.5.4. Prostate Cancer

        8.5.5. Others

    8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

        8.6.1. Breast Cancer

        8.6.2. Non-Small Cell Lung Cancer (NSCLC)

        8.6.3. Bladder Cancer

        8.6.4. Others

    8.7. Market Attractiveness Analysis

9. Latin America Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    9.1. Key Highlights

    9.2. Pricing Analysis

    9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        9.3.1. By Country

        9.3.2. By Test Type

        9.3.3. By In Situ Hybridization (ISH) Test

    9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        9.4.1. Brazil

        9.4.2. Mexico

        9.4.3. Rest of Latin America

    9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

        9.5.1. Breast Cancer

        9.5.2. Stomach (Gastric) Cancer

        9.5.3. Colorectal Cancer

        9.5.4. Prostate Cancer

        9.5.5. Others

    9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

        9.6.1. Breast Cancer

        9.6.2. Non-Small Cell Lung Cancer (NSCLC)

        9.6.3. Bladder Cancer

        9.6.4. Others

    9.7. Market Attractiveness Analysis

10. Middle East & Africa Cancer Tissue Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    10.1. Key Highlights

    10.2. Pricing Analysis

    10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        10.3.1. By Country

        10.3.2. By Test Type

        10.3.3. By In Situ Hybridization (ISH) Test

    10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        10.4.1. GCC

        10.4.2. Egypt

        10.4.3. South Africa

        10.4.4. Northern Africa

        10.4.5. Rest of Middle East & Africa

    10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030

        10.5.1. Breast Cancer

        10.5.2. Stomach (Gastric) Cancer

        10.5.3. Colorectal Cancer

        10.5.4. Prostate Cancer

        10.5.5. Others

    10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By In Situ Hybridization (ISH) Test, 2023 - 2030

        10.6.1. Breast Cancer

        10.6.2. Non-Small Cell Lung Cancer (NSCLC)

        10.6.3. Bladder Cancer

        10.6.4. Others

    10.7. Market Attractiveness Analysis

11. Competition Landscape

    11.1. Market Share Analysis, 2022

    11.2. Market Structure

        11.2.1. Competition Intensity Mapping By Market  

        11.2.2. Competition Dashboard

        11.2.3. Apparent Product Capacity

    11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

        11.3.1. Abbott Laboratories

            11.3.1.1. Overview

            11.3.1.2. Segments and Product

            11.3.1.3. Key Financials

            11.3.1.4. Market Developments

            11.3.1.5. Market Strategy

        11.3.2. F. Hoffmann-La Roche Ltd.

            11.3.2.1. Overview

            11.3.2.2. Segments and Product

            11.3.2.3. Key Financials

            11.3.2.4. Market Developments

            11.3.2.5. Market Strategy

        11.3.3. Thermo Fisher Scientific Inc.

            11.3.3.1. Overview

            11.3.3.2. Segments and Product

            11.3.3.3. Key Financials

            11.3.3.4. Market Developments

            11.3.3.5. Market Strategy

        11.3.4. Ventana Medical Systems, Inc.

            11.3.4.1. Overview

            11.3.4.2. Segments and Product

            11.3.4.3. Key Financials

            11.3.4.4. Market Developments

            11.3.4.5. Market Strategy

        11.3.5. Bio Rad Laboratories Inc.

            11.3.5.1. Overview

            11.3.5.2. Segments and Product

            11.3.5.3. Key Financials

            11.3.5.4. Market Developments

            11.3.5.5. Market Strategy

        11.3.6. Enzo Life Sciences, Inc.

            11.3.6.1. Overview

            11.3.6.2. Segments and Product

            11.3.6.3. Key Financials

            11.3.6.4. Market Developments

            11.3.6.5. Market Strategy

        11.3.7. Abcam plc.

            11.3.7.1. Overview

            11.3.7.2. Segments and Product

            11.3.7.3. Key Financials

            11.3.7.4. Market Developments

            11.3.7.5. Market Strategy

        11.3.8. BioGenex

            11.3.8.1. Overview

            11.3.8.2. Segments and Product

            11.3.8.3. Key Financials

            11.3.8.4. Market Developments

            11.3.8.5. Market Strategy

        11.3.9. Cell Signalling Technology, Inc.

            11.3.9.1. Overview

            11.3.9.2. Segments and Product

            11.3.9.3. Key Financials

            11.3.9.4. Market Developments

            11.3.9.5. Market Strategy

        11.3.10. Agilent Technologies, Inc.

            11.3.10.1. Overview

            11.3.10.2. Segments and Product

            11.3.10.3. Key Financials

            11.3.10.4. Market Developments

            11.3.10.5. Market Strategy

        11.3.11. PerkinElmer Inc.

            11.3.11.1. Overview

            11.3.11.2. Segments and Product

            11.3.11.3. Key Financials

            11.3.11.4. Market Developments

            11.3.11.5. Market Strategy

        11.3.12. Bio SB

            11.3.12.1. Overview

            11.3.12.2. Segments and Product

            11.3.12.3. Key Financials

            11.3.12.4. Market Developments

            11.3.12.5. Market Strategy

        11.3.13. Cancer Genetics Inc.

            11.3.13.1. Overview

            11.3.13.2. Segments and Product

            11.3.13.3. Key Financials

            11.3.13.4. Market Developments

            11.3.13.5. Market Strategy

        11.3.14. Danaher Corporation

            11.3.14.1. Overview

            11.3.14.2. Segments and Product

            11.3.14.3. Key Financials

            11.3.14.4. Market Developments

            11.3.14.5. Market Strategy

        11.3.15. ROSETTA GENOMICS

            11.3.15.1. Overview

            11.3.15.2. Segments and Product

            11.3.15.3. Key Financials

            11.3.15.4. Market Developments

            11.3.15.5. Market Strategy

        11.3.16. Nanoprobes, Inc.

            11.3.16.1. Overview

            11.3.16.2. Segments and Product

            11.3.16.3. Key Financials

            11.3.16.4. Market Developments

            11.3.16.5. Market Strategy

        11.3.17. Creative-Biolabs

            11.3.17.1. Overview

            11.3.17.2. Segments and Product

            11.3.17.3. Key Financials

            11.3.17.4. Market Developments

            11.3.17.5. Market Strategy

        11.3.18. Enzo Life Sciences, Inc.

            11.3.18.1. Overview

            11.3.18.2. Segments and Product

            11.3.18.3. Key Financials

            11.3.18.4. Market Developments

            11.3.18.5. Market Strategy

        11.3.19. Sigma-Aldrich Co., LLC

            11.3.19.1. Overview

            11.3.19.2. Segments and Product

            11.3.19.3. Key Financials

            11.3.19.4. Market Developments

            11.3.19.5. Market Strategy

12. Appendix

    12.1. Research Methodology

    12.2. Research Assumptions

    12.3. Acronyms and Abbreviations

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate